Q1 2023 Evonik

Q1 adj. EBITDA of only €409 m due to low volumes and despite positive pricing in Specialties;
PA12 ramp-up driving Smart Materials, slow start in Specialty Additives, price pressure in Animal Nutrition and C4.

Positive pricing
in Specialties
despite low volumes.

 

Free Trial

Step 1 of 2

Name(Required)

By pressing “Send” you agree to the Privacy Policy of this site

No Credit Card needed, after filling up the form you will receive your Free-Trial login information in 24 to 48 hours by e-mail.

ImprintPrivacy Policy

All Rights Reserved © aicorite.com